Endocrine Signalling Research

CJC-1295 (No DAC)

CJC-1295 (No DAC) is a modified growth-hormone-releasing hormone (GHRH) analogue. It is studied within endocrine signalling research.

Identity

Amino acid sequenceTyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

Molecular weight3,367.9 g/mol

CAS numberN/A

Physical formLyophilised Powder

Storage−20°C, desiccated, dark

Terms used here are defined in the glossary.

Batches tested

Every batch is analysed by an independent laboratory before release. Results below describe the batch named, and do not carry across to any other batch.

CJC-10-2607

2 August 2026 · Ozcanium Analytics

99.23% purity

10.08mg net content

How to verify what you have

Read the batch number from the vial label, find that batch above or in the COA Library, and open its certificate. The report code on the certificate can be checked directly with the testing laboratory, so verification does not depend on us.

The methods behind those figures are set out in Testing Standards.

Supply

Supplied as lyophilised powder, Express Post Australia-wide from Melbourne. See CJC-1295 (No DAC) for sizes and current pricing, and Supply Conditions for the terms of supply.

This page states identity, specifications and test results only. No guidance is given on use, preparation or quantities. For research purposes only. Not for human consumption, therapeutic use, veterinary use, diagnostic use, or clinical application.